R.D. Jolly was project leader who conceived and managed the research and was principally responsible for writing. N.R. Marshall was responsible for management and clinical procedures involving the experimental dogs. A. Hartman was the radiologist who managed and interpreted the CT scans. K.M. Hemsley and L.K. Winner were responsible for the assays of SGSH enzyme. J. Marshall performed the statistical analyses.
Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture
Version of Record online: 9 SEP 2013
© 2012 Massey University. Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society
Neuropathology and Applied Neurobiology
Volume 39, Issue 6, pages 681–692, October 2013
How to Cite
Jolly, R. D., Marshall, N. R., Marshall, J., Hartman, A., Hemsley, K. M. and Winner, L. K. (2013), Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture. Neuropathology and Applied Neurobiology, 39: 681–692. doi: 10.1111/nan.12010
- Issue online: 9 SEP 2013
- Version of Record online: 9 SEP 2013
- Accepted manuscript online: 17 DEC 2012 08:54PM EST
- Manuscript Accepted: 10 DEC 2012
- Manuscript Received: 8 JUL 2012
- The Society for Mucopolysaccharide Diseases
- Lysosomal Storage Diseases New Zealand
- Palmerston North Medical Research Foundation
- Shire Human Genetic Therapies
- cerebellomedullary cistern;
- cerebrospinal fluid;
- intracisternal enzyme replacement;
- lysosomal storage disease;
- mucopolysaccharidosis IIIA;
To investigate routes of dispersal of enzyme, its regional uptake and the effect of posture when replacement enzyme is administered directly into the cerebrospinal fluid (CSF).
Dispersal pathways of particles and solutes were investigated using intracisternal injections of india ink with visual assessment, and a contrast medium (Iohexol) with computer tomography (CT). Replacement enzyme was measured at 46 loci within the central nervous system (CNS) in four groups of dogs subjected to different post-injection postural changes.
India ink and CT studies showed dispersal pathways for CSF to be mainly via cisterns and sulci. Replacement enzyme reached all areas of the CNS tested, although mean concentrations varied 49-fold over different areas of the brain. Posttreatment posture had only modest effects on enzyme uptake in limited anatomical sites.
Dispersal of solutes after injection is rapid and initially enhanced by the injection process. Preferential pathways for CSF flow in the subarachnoid spaces of the brain involve cisterns and sulci. The splenial and suprasplenial sulci in particular appear important conduits for dispersal to more dorsal and rostral areas of the brain. Expansion and contraction of these sulci during brain pulsation is considered important to the forward flow of solutes in CSF through these compartments. Following intracisternal enzyme replacement therapy, enzyme reached all areas of the brain, but there was considerable disparity of enzyme uptake with some areas recording much higher levels than others. Posttreatment posture made only modest differences to enzyme uptake.